1. Home
  2. CYTK vs NNN Comparison

CYTK vs NNN Comparison

Compare CYTK & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$59.89

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo NNN REIT Inc.

NNN

NNN REIT Inc.

N/A

Current Price

$44.80

Market Cap

8.5B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
NNN
Founded
1997
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.5B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
CYTK
NNN
Price
$59.89
$44.80
Analyst Decision
Strong Buy
Hold
Analyst Count
18
6
Target Price
$87.56
$43.67
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
5.32%
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$13,368,000.00
$926,213,000.00
Revenue This Year
$9.79
$5.70
Revenue Next Year
$302.66
$5.21
P/E Ratio
N/A
$21.78
Revenue Growth
N/A
6.55
52 Week Low
$29.31
$35.80
52 Week High
$70.98
$46.03

Technical Indicators

Market Signals
Indicator
CYTK
NNN
Relative Strength Index (RSI) 40.30 56.12
Support Level $59.25 $40.70
Resistance Level $65.93 $45.75
Average True Range (ATR) 2.65 0.70
MACD -0.32 -0.11
Stochastic Oscillator 3.98 39.81

Price Performance

Historical Comparison
CYTK
NNN

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.

Share on Social Networks: